Announcement
Collapse
No announcement yet.
Treatments
Collapse
There are no conversations in this channel.
Please log in to your account to view your subscribed posts.
Topics | Statistics | Last Post | ||
---|---|---|---|---|
Open Forum Infect Dis . Real-world Clinical Outcomes of Bebtelovimab and Sotrovimab Treatment of High-risk Persons With Coronavirus Disease 2019 During the Omicron Epoch
by tetano
Started by tetano, October 11, 2022, 04:48 AM
|
0 responses
24 views
0 likes
|
Last Post
by tetano
October 11, 2022, 04:48 AM
|
||
Started by tetano, October 11, 2022, 03:54 AM
|
0 responses
21 views
0 likes
|
Last Post
by tetano
October 11, 2022, 03:54 AM
|
||
Started by tetano, October 11, 2022, 03:53 AM
|
0 responses
23 views
0 likes
|
Last Post
by tetano
October 11, 2022, 03:53 AM
|
||
Started by tetano, October 8, 2022, 02:15 AM
|
0 responses
38 views
0 likes
|
Last Post
by tetano
October 8, 2022, 02:15 AM
|
||
Cureus . Current Use of Baricitinib in COVID-19 Treatment and Its Future: An Updated Literature Review
by tetano
Started by tetano, October 7, 2022, 04:11 AM
|
0 responses
27 views
0 likes
|
Last Post
by tetano
October 7, 2022, 04:11 AM
|
||
Clin Infect Dis . Clinical, Virologic, and Immunologic Evaluation of Symptomatic Coronavirus Disease 2019 Rebound Following Nirmatrelvir/Ritonavir Treatment
by tetano
Started by tetano, October 7, 2022, 04:07 AM
|
0 responses
28 views
0 likes
|
Last Post
by tetano
October 7, 2022, 04:07 AM
|
||
Started by tetano, October 7, 2022, 03:08 AM
|
0 responses
32 views
0 likes
|
Last Post
by tetano
October 7, 2022, 03:08 AM
|
||
Rapid initiation of nasal saline irrigation to reduce severity in high-risk COVID+ outpatients
by Emily
Started by Emily, October 7, 2022, 02:07 AM
|
0 responses
72 views
0 likes
|
Last Post
by Emily
October 7, 2022, 02:07 AM
|
||
Nat Commun . IgG-like bispecific antibodies with potent and synergistic neutralization against circulating SARS-CoV-2 variants of concern
by tetano
Started by tetano, October 6, 2022, 04:08 AM
|
0 responses
19 views
0 likes
|
Last Post
by tetano
October 6, 2022, 04:08 AM
|
||
Cell Rep Med . A molecularly engineered, broad-spectrum anti-coronavirus lectin inhibits SARS-CoV-2 and MERS-CoV infection in vivo
by tetano
Started by tetano, October 6, 2022, 04:01 AM
|
0 responses
27 views
0 likes
|
Last Post
by tetano
October 6, 2022, 04:01 AM
|
No topics found.
-
Page of 0
-
Filter